Mitek Chairman of the Board Scott Carter's Comments 'Today, we are reiterating our fiscal 2024 guidance. Our recent product innovations, including Check Fraud Defender, MiVIP, MiPass, and ID R&D ...
01Net
-
7 ore fa
|
|
|
... to its Board of Directors as an independent director. The backlog status is a point in time measure but in total reflects underlying pacing of orders: Fiscal Quarter Ended Beginning Backlog New ...
01Net
-
10-5-2024
|
|
|
On April 5, 2024, our Board of Directors declared a quarterly cash dividend of $0.30 for each share ... Raising FY24 Guidance Maximus is raising fiscal year 2024 guidance following second quarter ...
01Net
-
9-5-2024
|
|
|
... Inc., is a member of the board of directors of HashiCorp, Inc. and Feedzai, Inc, and is a former ... announced on August 1, 2023, in the third quarter of fiscal 2024. As of March 31, 2024, a total of 1,...
01Net
-
8-5-2024
|
|
|
...reflects our positive long - term view on our underlying business fundamentals and the Board's ... see 'Risk Factors' in the Company's Annual Report on Form 10 - K for the fiscal year ended September 30,...
01Net
-
7-5-2024
|
|
|
...' said Till Reuter, Board Director for Fox Robotics and former CEO of Kuka Robotics. 'Fox Robotics ... Updates Fiscal 2024 Guidance Business Wire Business Wire - 7 Maggio 2024 Reported sales down 6.6% ...
01Net
-
7-5-2024
|
|
|
Reports First Quarter Fiscal Year 2024 Financial Results ST. LOUIS-(BUSINESS WIRE)- Perficient, Inc. (Nasdaq: PRFT) ('... 'Today's announcement is the result of a comprehensive review by the Board to ...
01Net
-
5-5-2024
|
|
|
... today announced it will issue financial results for the Company's first quarter fiscal year 2024 ... including as a result of changes to the Company's board of directors or management; the possibility ...
01Net
-
3-5-2024
|
|
|
|
Malgrado tutti questi sforzi, il rispetto delle regole nell'Unione è stato assai diseguale: secondo lo European Fiscal Board, un organo indipendente di consulenza della Commissione, la compliance in ...
Torino Oggi.it
-
3-5-2024
|
|
|
|
... the visionary founder and former CEO of CREAPHARM, to the Myonex Board of Directors. His decision ... Creapharm was advised in France on the M&A legal part by ARST Avocats and on the fiscal and ...
Adnkronos
-
2-5-2024
|
|
|